Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007

被引:122
|
作者
Albores-Saavedra, Jorge [1 ,2 ]
Schwartz, Arnold M. [3 ]
Henson, Donald E. [4 ]
Kostun, Lara [4 ]
Hart, Alexandra [4 ]
Angeles-Albores, David [1 ,2 ]
Chable-Montero, Fredy [1 ,2 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Pathol, Mexico City 14000, DF, Mexico
[2] Med Sur Clin & Fdn, Mexico City 14000, DF, Mexico
[3] George Washington Univ Hosp, Dept Pathol, Washington, DC 20037 USA
[4] George Washington Canc Inst, Washington, DC 20037 USA
关键词
Cutaneous angiosarcoma; Anatomical site; Histologic grade; Survival rate; COMPLICATING XERODERMA-PIGMENTOSUM; EPITHELIOID ANGIOSARCOMA; SOFT-TISSUE; RETINOBLASTOMA; DIAGNOSIS; SARCOMAS; SCALP; RISK; SKIN;
D O I
10.1016/j.anndiagpath.2010.07.012
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cutaneous angiosarcoma is an aggressive malignant mesenchymal vasoformative neoplasm that accounts for 1% of all soft tissue sarcomas. Using data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program, we analyzed the demographics and survival of cutaneous angiosarcoma. The Surveillance, Epidemiology, and End Results program recorded 434 cases of cutaneous angiosarcoma from 1973 to 2007. The incidence was nearly the same in men (222 cases) and women (212 cases). Most patients were white (88%) with a mean age of 73 years. African Americans made up only 4% of the cases. Two hundred seventy (62%) cases were tumors of the head and neck, whereas 106 (24%) cases arose in the skin of the trunk. Grade was recorded in 194 cases (45%): 28 were grade 1, 44 were grade 11, 60 were grade III, and 62 were grade IV. Survival rates of cutaneous angiosarcoma correlated with age, anatomical site, and stage of disease. Patients younger than 50 years had a 10-year relative survival rate of 71.7%, whereas patients 50 years and older had a 36.8% 10-year survival rate. Tumors of the scalp and neck resulted in a 13.8% 10-year relative survival rate, whereas tumors arising in the trunk resulted in a 75.3% 10-year survival rate. Tumors localized to the skin had better prognosis (53.6% 10-year relative survival rate) than those with regional or distant stage (19.0% and 6.2%). Twenty-six percent of patients with angiosarcoma had a prior primary. Cutaneous angiosarcomas arise predominantly in the head and neck of white individuals older than 60 years. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:93 / 97
页数:5
相关论文
共 50 条
  • [41] Race/ethnicity and advanced stage of renal cell carcinoma in adults: results from surveillance, epidemiology, and end results program 2007-2015
    Dobyns, Alyssa C.
    Coutelle, Nino A.
    Suthumphong, Corey Y.
    Rodriguez, Pura E.
    Castro, Grettel
    Varella, Marcia H.
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2022, 31 (02) : 172 - 177
  • [42] Racial and gender disparities in stage at diagnosis for bladder cancer: Results from the surveillance, epidemiology, and end results (SEER) program, 2007 to 2016.
    Gupta, Sachin
    Joshi, Monika
    Weng, Xingran
    Wang, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Primary malignant neoplasms of the appendix -: A population-based study from the surveillance, epidemiology and end-results program, 1973-1998
    McCusker, ME
    Coté, TR
    Clegg, LX
    Sobin, LH
    CANCER, 2002, 94 (12) : 3307 - 3312
  • [44] Prognostic factors among single primary gliosarcoma cases: A study using Surveillance, Epidemiology, and End Results data from 1973-2013
    Chen, Bin
    Liu, Bin
    Wu, Chao
    Wang, Zhenyu
    CANCER MEDICINE, 2019, 8 (14): : 6233 - 6242
  • [45] Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program
    Meeks, Joshua J.
    Zhao, Lee C.
    Cashy, John
    Kundu, Shilajit
    BJU INTERNATIONAL, 2012, 109 (06) : 831 - 834
  • [46] Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the surveillance, epidemiology, and end results database
    Yu, James B.
    Blitzblau, Rachel C.
    Decker, Roy H.
    Housman, Douglas M.
    Wilson, Lynn D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1483 - 1488
  • [47] Chemotherapy in Esthesioneuroblastoma/Olfactory Neuroblastoma An Analysis of the Surveillance Epidemiology and End Results (SEER) 1973-2015 Database
    Cranmer, Lee D.
    Chau, Bonny
    Rockhill, Jason K.
    Ferreira, Manuel, Jr.
    Liao, Jay J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (03): : 203 - 209
  • [48] INCIDENCE OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA FROM 1992 THROUGH 2007: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS ANALYSIS
    Park, Caroline
    Tyburski, John
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 : S6 - S6
  • [49] Re: "Mesothelioma trends in the United States: An update based on surveillance, epidemiology, and end results program data for 1973 through 2003"
    Lange, JH
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (08) : 823 - 823
  • [50] The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004)
    Beebe-Dimmer, Jennifer L.
    Cetin, Karynsa
    Fryzek, Jon P.
    Schuetze, Scott M.
    Schwartz, Kendra
    RARE TUMORS, 2009, 1 (02)